Eradicating Infectious Disease: Can We and Should We? by Russell, Clark Donald
Eradicating infectious disease: can we and should we?
Clark Donald Russell*
College of Medicine and Veterinary Medicine, The University of Edinburgh, Edinburgh, UK
*Correspondence: c.d.russell-2@sms.ed.ac.uk
“Eradication of microbial disease is a will-
o’-the-wisp; pursuing it leads into a morass 
of hazy biological concepts and half truths.” 
These are the pessimistic words of René 
Dubos in 1965, encapsulating the challenges 
of attempting to eradicate infectious disease. 
In 1979, smallpox became the first infection 
to be eradicated, a huge triumph for science 
and humanity. Sadly, this impressive feat has 
only been replicated once since then with 
the eradication of rinderpest virus in 2011, 
and the words of Dubos seem as relevant 
today as they did in 1965.
As the only two infections eradicated to 
date are viral, it is tempting to assume that 
viruses are the ideal candidates for eradica-
tion. To some extent, this is true. Viruses are 
obligate intracellular pathogens and if denied 
access to host cells through immunization by 
vaccination, transmission is prevented, and 
the virus will be unable to replicate, leading 
to its extinction. Smallpox was a sensible tar-
get for eradication as the virus had no animal 
reservoir or latent phase, an effective single 
dose vaccine existed and infection produced 
obvious clinical signs, allowing effective sur-
veillance for infection (Henderson, 1998). By 
2006, eradication efforts had reduced the 
worldwide incidence of poliomyelitis infec-
tion by 99% through the oral polio vaccine 
(OPV; Arita et al., 2006). The remaining 
1% seems to be clustered in endemic areas 
(India, Pakistan, and certain African coun-
tries) and the main barrier now is not bio-
logical, but operational, e.g., security issues in 
Afghanistan and a funding deficit. However, 
a problem with live vaccines such as the OPV 
is that the strain can potentially revert back 
to a pathogenic form and this has been 
encountered with the OPV. Furthermore, 
unlike smallpox, poliomyelitis can be sub-
clinical, making vaccine targeting difficult. 
On a positive note, the complete eradication 
of polio from the Americas suggests polio-
myelitis eradication is possible.
However, eradication of viral diseases is 
not a straightforward process. Indeed, there 
are viral diseases that appear   impossible to 
eradicate due to certain characteristics of 
the causative virus. Herpes simplex virus 
resides latent in neurons, from where infec-
tion can reactivate. One cannot identify 
latently infected individuals clinically but 
they have the potential to become infec-
tive when the virus reactivates. If a vac-
cination program was stopped before all 
latently infected members of a population 
had died, reactivation of latent infections 
would result in the infection of naïve, non-
vaccinated individuals, taking the program 
back to square one. Influenza A is an RNA 
virus whose antigens are constantly chang-
ing due to antigenic shift and drift (Carrat 
and Flahault, 2007). Antigenic drift involves 
point mutations in the hemagglutinin and 
or neuraminidase genes, encoding envelope 
glycoproteins, thus reducing the binding 
affinity of antibodies raised against previ-
ous strains. This explains why individuals 
can be reinfected with influenza and why 
the content of the seasonal vaccine must 
be altered annually. Antigenic shift is the 
genetic reassortment of genome segments 
between animal and human strains leading 
to the expression of novel hemagglutinin 
subtypes. It essentially creates a “new” virus 
to which no pre-existing immunity exists 
and is the process behind dangerous pan-
demics such as the 1918 “Spanish Flu.” The 
net result of this antigenic instability is a 
virus that is constantly changing and can 
thus evade immunity to a previous vari-
ant. Hepatitis C virus (HCV) and human 
immunodeficiency virus (HIV) are other 
RNA viruses that pose similar problems 
in terms of their rapid rate of evolution, 
outpacing the immune system. The use 
of more conserved antigens may provide 
a solution to this problem but the error 
prone nature of the RNA dependent RNA 
polymerase used by influenza and HCV 
represents a fundamental problem in that 
even conserved genes have the potential to 
mutate rapidly under correct selective pres-
sures. HIV causes the acquired immuno-
deficiency syndrome, resulting in 2 million 
deaths per year. HIV-1 was first identified in 
1983 and is thought to have first entered the 
human population in 1931 following simian 
immunodeficiency viruses making a spe-
cies jump from primate to man (Gao et al., 
1999; Korber et al., 2000). This cross-species 
transmission event was followed by adap-
tation of the virus to its new host, giving 
rise to the HIV strains seen today, capable 
of human–human transmission. Similarly, 
the 2009 pandemic swine-origin influenza 
A (H1N1) virus originated from recom-
bination between several influenza virus 
strains circulating in swine. This antigenic 
shift resulted in a virus with the potential for 
human–human spread at a pandemic level, 
fine tuned by selection pressures following 
the cross-species transmission event (Smith 
et al., 2009).
Bacteria represent a bigger problem in 
that, unlike viruses, few pathogenic bacteria 
are obligate pathogens. Many are opportun-
istic pathogens: these can be members of 
the normal flora that only cause disease if 
the host is immunodeficient or they access 
a normally sterile area. An example is 
Staphylococcus aureus, which can be found 
asymptomatically colonizing the nasophar-
ynx. Bacteria such as Pseudomonas aerugi-
nosa and spores of Bacillus anthracis can 
survive in the environment, without infec-
tion of their host. A further complication 
is that many bacteria have animal reser-
voirs, e.g., Escherichia coli O157 asympto-
matically colonizes the terminal rectum of 
cattle (Naylor et al., 2003). Cattle are well 
controlled animals and a vaccine program 
in cattle stands a better chance of eradicat-
ing infection than, for example, eradication 
of Yersinia pestis from it’s rodent reservoir. 
Therefore, the nature of the bacteria–host 
relationship is a significant barrier to eradi-
cation of most bacterial infections. On the 
other hand, Chlamydia trachomatis is an 
obligate intracellular pathogen that has 
undergone genome reduction, losing its 
capability for free living. Since humans 
are an essential part of its lifecycle and it 
has no known animal reservoir, it appears 
potentially eradicable. A successful vaccine 
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resistant strains of microorganism nul-
lify the efficacy of these drugs as a control 
measure. However, something that Pasteur 
may not have considered is the possibly 
deleterious effect to man of eradicating 
certain infections. This school of thought 
is currently not far from the “morass of hazy 
biological concepts” of Dubos but ongoing 
research into the symbiotic interactions 
between even pathogenic bacteria and 
their hosts is likely to yield very interest-
ing data. Humans have co-evolved with 
microbes and it is too simplistic to con-
sider the eradication of microbial disease 
entirely beneficial.
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in the incidence of the constellation of 
gastro-esophageal reflux disease, Barrett’s 
esophagus, and esophageal adenocarci-
noma (el-Serag and Sonnenberg, 1998; 
Blaser and Atherton, 2004). Furthermore, 
H. pylori clearance appears to result in 
increased ghrelin secretion by the stom-
ach (a hormone that stimulates hunger). 
It is hypothesized that this lack of H. Pylori 
mediated ghrelin downregulation in chil-
dren (due to reduced H. pylori transmis-
sion) could be related to the increasing 
incidence of obesity in children, along 
with the metabolic syndrome (el-Serag and 
Sonnenberg, 1998; Blaser and Atherton, 
2004; Falkow, 2006). In an experimental 
model of chronic Salmonella typhimurium 
infection in mice, a significant peripheral 
blood transcriptional profile signature 
can be seen even by the time there is no 
bacteremia and only low numbers of bac-
teria are found in the organs. This signa-
ture involves genes of both the adaptive 
and innate branches of the immune sys-
tem. Therefore, this model system shows 
that persistent infection results in a long-
term, potentially lifelong effect on host 
immune regulation (Falkow, 2006). Taken 
together, all of these examples show how 
the microbe–host interaction is more com-
plex than previously thought. Bugs don’t 
equal disease. In some instances, infection 
by pathogenic organisms appears to have 
beneficial effects for the host and this must 
be fully explored to fully understand the 
consequences of eradicating any infection.
Louis Pasteur stated that “it is within 
the power of man to eradicate infection from 
the earth.” Currently, this is far from the 
case. Viral disease may represent an easier 
target than bacterial disease, but there 
are many biological properties of viruses 
that stand in the way of eradication using 
current technology and current ways of 
thinking. Infectious diseases that cannot 
be eradicated can usually be controlled 
to some extent, be it through the use of 
antimicrobial chemotherapy, vaccinations, 
or behavioral changes. A major barrier 
to such control is inadequate healthcare 
provision in developing countries, who 
bear the brunt of most infectious disease. 
Therefore, eradication of such healthcare 
inequalities would help a long way toward 
relieving the global burden of infectious 
diseases. Furthermore, antimicrobial 
drugs must be used more carefully and 
has not yet been produced and future hopes 
include DNA vaccines or a live attenuated 
vaccine (Brunham et al., 2000; Schautteet 
et al., 2011).
Environmental efforts can be used 
toward eradicating an infection, as exem-
plified by dracunculiasis, caused by 
Dracunculus medinensis. Humans are the 
only host for D. medinensis but no vac-
cines exist. Infection occurs through drink-
ing contaminated water and thus filtering 
water to remove infectivity can prevent 
transmission (Cairncross et al., 2002). This 
operates in tandem with efforts to remove 
the worms from blisters; preventing them 
entering water.
So far, we have considered some of the 
practical problems with eradicating an 
infection, assuming that eradication is 
indeed desirable. Whilst for some infec-
tions such as HIV, eradication is clearly a 
desirable goal, there are others that may 
require more careful thought. Clostridium 
difficile pseudomembranous colitis is an 
obvious example of the dangers of broad-
sweep microbe killing in humans. A less 
obvious example is the case of Streptococcus 
pneumoniae vaccination. S. pneumoniae is 
the main etiological agent of pneumonia 
and the pneumococcal vaccine is used in 
individuals with pre-existing lung disease 
to protect from infection by virulent strains 
of this bacteria. However, S. pneumoniae is 
a member of the endogenous flora of the 
nasopharynx, colonizing this site asymp-
tomatically. It appears that colonization by 
S. Pneumoniae strains found in the vaccine 
is negatively associated with S. aureus colo-
nization, possibly due to the two bacteria 
being in competition with each other in 
the nasopharynx (Regev-Yochay et al., 
2004). It is interesting to consider the 
role this may have in driving the rise in 
incidence of community acquired methi-
cillin resistant S. aureus infection (Blaser 
and Falkow, 2009).  Helicobacter pylori 
chronically colonizes gastric mucosa and 
is associated with 95% of duodenal and 
75% of gastric ulcers and also with gas-
tric cancer. H. pylori gastric colonization 
has fallen markedly, thanks to antibiotic 
treatment and reduced transmission, and 
this has culminated in a welcome decrease 
in the incidence of peptic ulcer and gas-
tric cancer (el-Serag and Sonnenberg, 
1998). However, there is evidence that 
this is associated with a reciprocal rise 
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